A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and Ozempic, the company announced Thursday. The once-daily pill, called orforglipron, helped patients with Type 2 diabetes lower their drug sugar levels and lose weight during late-stage trials, the drugmaker said. The trial results are being...
Civil rights work is slowing as Trump dismantles the Education Department, agency data showsData from the Education Department shows the pace at which it resolves civil rights complaints has slowed as the Trump administration dismantles the agencyJuly 18, 2025
- yesterday, 9:57 PM
- abcnews.go.com
- 0
No comments